Legis Daily

To authorize grants to address substance use during COVID-19.

USA116th CongressHR-6620| House 
| Updated: 4/24/2020
Ann M. Kuster

Ann M. Kuster

Democratic Representative

New Hampshire

Cosponsors (2)
John Katko (Republican)David J. Trone (Democratic)

Energy and Commerce Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
This bill requires the Substance Abuse and Mental Health Services Administration (SAMHSA) to award grants to eligible jurisdictions and community-based organizations to address the harms of substance misuse, including by encouraging actions to reduce health impacts of substance use during national disasters and emergencies. SAMHSA shall prioritize grants by accounting for such factors as drug overdose death rates.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Apr 24, 2020
Introduced in House
Apr 24, 2020
Referred to the House Committee on Energy and Commerce.
  • April 24, 2020
    Introduced in House


  • April 24, 2020
    Referred to the House Committee on Energy and Commerce.

Health

Cardiovascular and respiratory healthDigestive and metabolic diseasesDrug, alcohol, tobacco useEmergency medical services and trauma careHealth programs administration and fundingHealth promotion and preventive careHealth technology, devices, suppliesHIV/AIDSInfectious and parasitic diseasesMental health

To authorize grants to address substance use during COVID-19.

USA116th CongressHR-6620| House 
| Updated: 4/24/2020
This bill requires the Substance Abuse and Mental Health Services Administration (SAMHSA) to award grants to eligible jurisdictions and community-based organizations to address the harms of substance misuse, including by encouraging actions to reduce health impacts of substance use during national disasters and emergencies. SAMHSA shall prioritize grants by accounting for such factors as drug overdose death rates.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Apr 24, 2020
Introduced in House
Apr 24, 2020
Referred to the House Committee on Energy and Commerce.
  • April 24, 2020
    Introduced in House


  • April 24, 2020
    Referred to the House Committee on Energy and Commerce.
Ann M. Kuster

Ann M. Kuster

Democratic Representative

New Hampshire

Cosponsors (2)
John Katko (Republican)David J. Trone (Democratic)

Energy and Commerce Committee

Health

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Cardiovascular and respiratory healthDigestive and metabolic diseasesDrug, alcohol, tobacco useEmergency medical services and trauma careHealth programs administration and fundingHealth promotion and preventive careHealth technology, devices, suppliesHIV/AIDSInfectious and parasitic diseasesMental health